ENvue Medical
US medical device maker of the ENvue electromagnetic navigation system for bedside enteral feeding-tube placement, merged with NanoVibronix (Nasdaq: FEED).
ENvue Medical, formerly known as ENvizion Medical, is a US medical device company that develops electromagnetic navigation technology for bedside placement of enteral feeding tubes in critical care settings. The company was founded in 2013 and is headquartered at 762 W. Algonquin Road, Arlington Heights, Illinois. Its core platform, the ENvue System, uses multiple body-worn sensors registered to predetermined anatomical landmarks to build a real-time body map, giving clinicians continuous visual steering guidance in three views as they thread a feeding tube from the nose or mouth into the stomach. The system includes lung-entry safety alerts intended to reduce the risk of misplacement into the airway, a known complication of blind feeding-tube insertion that can lead to aspiration pneumonia or lung injury. The ENvue System received FDA 510(k) clearance for adult patients and has been adopted by multiple US hospitals, with the company reporting thousands of successful tube placements to date. In August 2026 the company launched ENvue Drive, an expansion of its robotic-assisted feeding-tube placement line, extending the underlying True Body Navigation technology first used in the original ENvue System. CEO Doron Besser co-founded the company and led it from initial concept through FDA clearance and early US clinical adoption. In February 2025, ENvizion Medical merged with NanoVibronix, a maker of non-invasive therapeutic ultrasound devices (PainShield and UroShield) for pain management and urology; the combined public company trades on Nasdaq under the ticker FEED and now operates the enteral-navigation business alongside NanoVibronix's therapeutic device lines under shared leadership. The company positions its navigation system as an alternative to blind bedside placement and to routine X-ray confirmation, aiming to reduce placement time, radiation exposure, and complication rates in intensive-care and general hospital settings. ENvue Medical's business is concentrated in the hospital critical-care market, selling capital navigation consoles together with single-use guidance stylets and feeding tubes to institutional customers.
Primary type & automation activities this supplier delivers:
ENvue System
FDA-cleared electromagnetic navigation system guiding enteral feeding tube placement without X-ray confirmation.
Contact ENvue Medical
WEBSITE
https://envuemed.com/HEADQUARTERS
United States
Company Facts
Founded
2013
Primary Role
Manufacturer
Company Size
employees 10-50
Primary Region
North America
Annual Sales
-
Funding Stage
Public
Funding Total
-
Certifications & Memberships
ENvue Medical Launches ENvue Drive for Robotic Feeding Tube Placement
ENvue Medical Inc. has introduced ENvue Drive, a robotic-assisted tool designed for the automatic placement of feeding tubes. Built on the company's electromagnetic navigation platform, this innovative system integrates artificial intelligence and real-time navigation to enhance clinical workflow. Each year, over a million feeding tubes are inserted in the U.S., often relying on the clinician's experience, which can lead to a 3% to 5% misplacement rate. The significance of ENvue Drive lies in its potential to improve patient safety and procedural efficiency. Misplaced feeding tubes can lead to severe complications, including lung collapse. Dr. Doron Besser, CEO of ENvue Medical, emphasized that the system aims to simplify the procedure for clinicians while reducing costs for hospitals. The ENvue Drive utilizes a sensor at the end of the feeding tube, providing real-time visibility during placement and integrating AI navigation software to ensure accuracy. Looking ahead, ENvue Medical's system offers five degrees of freedom for enhanced flexibility during procedures. The integration of a high-refresh-rate sensor, which operates at approximately 40 times per second, allows for immediate feedback, minimizing delays. No further timeline was disclosed at the time of publication.
Artificial Intelligence Artificial Intelligence / Cognition Design / Development Healthcare Robotics Markets / Industries News
Korea Launches First Anti-Dumping Probe on Industrial Robots in 20 Years - A New regulatory Era for Robotics
South Korea launches its first anti-dumping investigation in 20 years as the U.S. Section 232 review puts robotics imports under national-security scrutiny.
